Prevention and treatment of low back pain: evidence, challenges, and promising directions

  • Nadine E. Foster
  • , Johannes R. Anema
  • , Dan Cherkin
  • , Roger Chou
  • , Steven P. Cohen
  • , Douglas P. Gross
  • , Paulo H. Ferreira
  • , Julie M. Fritz
  • , Bart W. Koes
  • , Wilco C. Peul
  • , Judith A. Turner
  • , Chris G. Maher
  • , Rachelle Buchbinder
  • , Jan Hartvigsen
  • , Dan Cherkin
  • , Nadine E. Foster
  • , Chris G. Maher
  • , Lancet Low Back Pain Series Working Group
  • , Martin Underwood (Member of author group)
  • , Maurits van Tulder (Member of author group)
  • Johannes R. Anema (Member of author group), Roger Chou (Member of author group), Stephen P. Cohen (Member of author group), Lucíola Menezes Costa (Member of author group), Peter Croft (Member of author group), Manuela Ferreira (Member of author group), Paulo H. Ferreira (Member of author group), Julie M. Fritz (Member of author group), Stéphane Genevay (Member of author group), Douglas P. Gross (Member of author group), Mark J. Hancock (Member of author group), Damian Hoy (Member of author group), Jaro Karppinen (Member of author group), Bart W. Koes (Member of author group), Alice Kongsted (Member of author group), Quinette Louw (Member of author group), Birgitta Öberg (Member of author group), Wilco C. Peul (Member of author group), Glenn Pransky (Member of author group), Mark Schoene (Member of author group), Joachim Sieper (Member of author group), Rob J. Smeets (Member of author group), Judith A. Turner (Member of author group), Anthony Woolf (Member of author group)

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Many clinical practice guidelines recommend similar approaches for the assessment and management of low back pain. Recommendations include use of a biopsychosocial framework to guide management with initial non-pharmacological treatment, including education that supports self-management and resumption of normal activities and exercise, and psychological programmes for those with persistent symptoms. Guidelines recommend prudent use of medication, imaging, and surgery. The recommendations are based on trials almost exclusively from high-income countries, focused mainly on treatments rather than on prevention, with limited data for cost-effectiveness. However, globally, gaps between evidence and practice exist, with limited use of recommended first-line treatments and inappropriately high use of imaging, rest, opioids, spinal injections, and surgery. Doing more of the same will not reduce back-related disability or its long-term consequences. The advances with the greatest potential are arguably those that align practice with the evidence, reduce the focus on spinal abnormalities, and ensure promotion of activity and function, including work participation. We have identified effective, promising, or emerging solutions that could offer new directions, but that need greater attention and further research to determine if they are appropriate for large-scale implementation. These potential solutions include focused strategies to implement best practice, the redesign of clinical pathways, integrated health and occupational interventions to reduce work disability, changes in compensation and disability claims policies, and public health and prevention strategies.

Original languageEnglish
JournalThe Lancet
Volume391
Issue number10137
Pages (from-to)2368-2383
ISSN0140-6736
DOIs
Publication statusPublished - 9. Jun 2018

Keywords

  • Analgesics, Opioid/administration & dosage
  • Chronic Pain/prevention & control
  • Cost-Benefit Analysis/standards
  • Diagnostic Imaging/economics
  • Female
  • Humans
  • Low Back Pain/economics
  • Male
  • Pain Management/economics
  • Practice Guidelines as Topic/standards
  • United States Public Health Service/standards
  • United States/epidemiology

Fingerprint

Dive into the research topics of 'Prevention and treatment of low back pain: evidence, challenges, and promising directions'. Together they form a unique fingerprint.

Cite this